{"id":28565,"date":"2014-08-18T08:58:45","date_gmt":"2014-08-18T12:58:45","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=28565"},"modified":"2014-08-18T08:58:45","modified_gmt":"2014-08-18T12:58:45","slug":"traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565","title":{"rendered":"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/18\/2014 (wallstreetpr) \u2013<strong> Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) <\/strong>has gained investor&#8217;s attention after the announcement of the development of <a href=\"http:\/\/blogs.wsj.com\/moneybeat\/2014\/08\/15\/as-ebola-outbreak-spreads-options-traders-bet-on-pharma-firm-tekmira\/\" target=\"_blank\">experimental treatment<\/a> that can get rid of the deathly virus Ebola. As soon as TKMR made this announcement, investors showed a lot of interest in trading options on it.<\/p>\n<p style=\"text-align: justify;\"><strong>When Did It Start? <\/strong><\/p>\n<p style=\"text-align: justify;\">Ebola has caused hundreds of deaths in African countries and so far medical science has failed to find a treatment of this deathly virus. Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has announced its experimental study on Ebola&#8217;s treatment at such a time when the entire world needs it; hence, the company has got the sudden attention of the investors. According to trade alert data, the total number of contracts exercised crossed 10,000 as per August 4, 2014. According to recent numbers, the contract volume touched 50,000 on Monday. All the call options will expire in the month of September. Call option is different from put and gives the trader the right to buy the underlying asset. There is no obligation if the contract holder will have to exercise the right.<\/p>\n<p style=\"text-align: justify;\">According to recent reports, the volatility has increased by a huge margin in last few days which indicate that the underlying asset may experience a wide swing. Livevol Pro made public a data report which showed that the thirty-day implied volatility touched the highest level on Monday since April 15, 2014. Implied volatility is but a standard of future volatility that is derived with the help of options prices.<\/p>\n<p style=\"text-align: justify;\">Brian Overby, an options analyst at TradeKing, said, &#8220;The volatility has remained very high even after the announcement of Q2 earnings that are a shock.&#8221; Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) stock is in demand that&#8217;s why people are trying their best to enter into the options market to exercise the contract. Recently WHO (World Health Organization) announced that it was interested in trying the experimental drug for Ebola after witnessing the size of its outbreak in West Africa.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has gained investor&#8217;s attention after the announcement of the development of experimental treatment that can get [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":18049,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[4911,8020,4910],"stock_ticker":[],"class_list":["post-28565","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-nasdaqtkmr","tag-tekmira-pharmaceuticals-corporation","tag-tekmira-pharmaceuticals-corporation-nasdaqtkmr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has gained investor&#8217;s attention after the announcement of the development of experimental treatment that can get [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-18T12:58:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"168\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola\",\"datePublished\":\"2014-08-18T12:58:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\"},\"wordCount\":337,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"keywords\":[\"NASDAQ:TKMR\",\"Tekmira Pharmaceuticals Corporation\",\"Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\",\"name\":\"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"datePublished\":\"2014-08-18T12:58:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg\",\"width\":300,\"height\":168},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565","og_locale":"en_US","og_type":"article","og_title":"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola - Wall Street PR","og_description":"Boston, MA 08\/18\/2014 (wallstreetpr) \u2013 Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) has gained investor&#8217;s attention after the announcement of the development of experimental treatment that can get [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-18T12:58:45+00:00","og_image":[{"width":300,"height":168,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola","datePublished":"2014-08-18T12:58:45+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565"},"wordCount":337,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","keywords":["NASDAQ:TKMR","Tekmira Pharmaceuticals Corporation","Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR)"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565","url":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565","name":"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","datePublished":"2014-08-18T12:58:45+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/03\/Tekmira-Pharmaceuticals-Corporation.jpg","width":300,"height":168},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/traders-look-to-execute-options-of-tekmira-pharmaceuticals-corporation-nasdaqtkmr-after-outbreak-of-ebola-28565#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Traders Look To Execute Options of Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) After Outbreak of Ebola"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=28565"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28565\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/18049"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=28565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=28565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=28565"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=28565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}